Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter to the Editor
  • Published:

A genetic deletion of the serotonin transporter greatly enhances the reinforcing properties of MDMA in rats

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1

References

  1. Schenk S, Colussi-Mas J, Do J, Bird J . J Drug Alcohol Res 2012; 1: 1–6.

    Article  Google Scholar 

  2. Han DD, Gu HH . BMC Pharmacol 2006; 6: 6.

    Article  Google Scholar 

  3. Carroll ME, Lac ST, Asencio M, Kragh R . Pharmacol Biochem Behav 1990; 35: 237–244.

    Article  CAS  Google Scholar 

  4. Baumann MH, Clark RD, Woolverton WL, Wee S, Blough BE, Rothman RB . J Pharmacol Exp Ther 2011; 337: 218–225.

    Article  CAS  Google Scholar 

  5. Homberg JR, Olivier JDA, Smits BMG, Mul JD, Mudde J, Verheul M et al Neuroscience 2007; 146: 1662–1676.

    Article  CAS  Google Scholar 

  6. Leccese AP, Lyness WH . Brain Res 1984; 303: 153–162.

    Article  CAS  Google Scholar 

  7. Pelloux Y, Dilleen R, Economidou D, Theobald D, Everitt BJ . Neuropsychopharmacology 2012; 37: 2505–2514.

    Article  CAS  Google Scholar 

  8. Bradbury S, Schenk S . Behav Pharmacol 2011; 22 (Suppl A): e56.

    Google Scholar 

  9. Brennan KA, Carati C, Lea RA, Fitzmaurice PS, Schenk S . Behav Pharmacol 2009; 20: 688–694.

    Article  CAS  Google Scholar 

  10. Schenk S . Neurosci Biobehav Rev 2011; 35: 1203–1218.

    Article  CAS  Google Scholar 

  11. Trigo JM, Renoir T, Lanfumey L, Hamon M, Lesch K-P, Robledo P et al Biol Psychiatry 2007; 62: 669–679.

    Article  CAS  Google Scholar 

  12. Easton N, Marsden CA . J Psychopharmacol 2006; 20: 194–210.

    Article  CAS  Google Scholar 

  13. Martin-Santos R, Torrens M, Poudevida S, Langohr K, Cuyas E, Pacifici R et al Addict Biol 2010; 15: 15–22.

    Article  CAS  Google Scholar 

  14. Roiser JP, Rogers RD, Cook LJ, Sahakian BJ . Psychopharmacology 2006; 188: 213–227.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

This study was supported by a grant from the Maurice & Phyllis Paykel Trust. We thank Professor John Miller for his valuable comments on the paper.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to B A Ellenbroek.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

PowerPoint slides

Rights and permissions

Reprints and permissions

About this article

Cite this article

Oakly, A., Brox, B., Schenk, S. et al. A genetic deletion of the serotonin transporter greatly enhances the reinforcing properties of MDMA in rats. Mol Psychiatry 19, 534–535 (2014). https://doi.org/10.1038/mp.2013.75

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/mp.2013.75

This article is cited by

Search

Quick links